Today's News | Note: News feeds may no longer be available for the articles on this page.

Study questions US flu vaccine guidelines 6:24 PM 8/20/2009
Reuters
Vaccinating school children and their parents against the flu is the best way to protect the nation from influenza. Priority should be given to people likely to spread the virus. ...

Drugmaker Dey warns against stolen drug purchase 8:17 AM 8/20/2009
Forbes
Mylan Inc's subsidiary Dey LP warns against the use of some cartons of Albuterol Sulfate Inhalation Solution that were on a stolen tractor trailer. The temperature-controlled supply chain may have been broken. Lot numbers - 9FE2 and 9GO1. ...

FDA panel votes against knee pain drug Durolane 7:05 AM 8/20/2009
Forbes
Durolane was developed by Q-Med AB and licensed to Smith & Nephew containing natural lubricant hyaluronic acid to provide cushioning and lubrication for patients with osteoarthritis in the knee. The US FDA advisory panel says it does not work. ...

GlaxoSmithKline's Hib Vaccine Hiberix Gets Accelerated FDA ... 5:16 AM 8/20/2009
RTT News
GlaxoSmithKline received approval from the US FDA for its Hiberix haemophilus b conjugate vaccine due to a shortage. ...

Merck Patent on Singulair Asthma Medicine Upheld 1:40 PM 8/19/2009
Bloomberg
Merck & Co won a court ruling that prevents Teva Pharmaceutical Industries from selling a copy of Merck’s best-selling drug Singulair until August 2012. ...

Gentium's liver drug fails late-stage trial; shrs fall 12:43 PM 8/19/2009
Forbes
Gentium SpA said its experimental drug defibrotide for severe veno-occlusive disease (VOD) missed the main goal of a late-stage study. VOD is a potentially life-threatening condition that typically occurs as a complication of stem-cell transplantation. ...

Forest, Glenmark Test Drug Oglemilast; Fails in Study 5:10 AM 8/19/2009
Wall Street Journal
India's Glenmark Pharmaceuticals and US-based Forest Laboratories said their drug oglemilast failed to meet desired targets in a mid-stage trial of chronic obstructive pulmonary disease (COPD). ...

Lilly Gives Up on Osteoporosis Drug 4:38 PM 8/18/2009
Wall Street Journal
Eli Lilly & Co said a Phase III study known as the "Generations" trial showed its osteoporosis drug arzoxifene missed several key efficacy endpoints. ...

US FDA warns J&J unit over study of new drug 12:07 PM 8/18/2009
Reuters
Johnson & Johnson's drug development unit has been warned by the US FDA over its failure to properly oversee two clinical trials of an experimental drug. ...

Durect licenses ADHD drug to Orient Pharma 8:55 AM 8/18/2009
Forbes
Durect granted Taiwan-based Orient Pharma rights to its Oradur-ADHD drug in selected Asian and South Pacific countries. ...

Sinovac says it finished swine flu vaccine tests 8:01 AM 8/18/2009
Forbes
Chinese drugmaker Sinovac Biotech Ltd completed clinical testing of a swine flu vaccine. It said its product was successful creating an immune system response to the virus. ...

Study backs Roche's new use of Avastin cancer drug 6:21 AM 8/18/2009
Reuters
Roche Holding AG said a study showed its drug Avastin lengthened the survival of patients with previously treated advanced HER2 negative breast cancer without the disease progressing. ...

Genmab slumps as Glaxo-partnered drug hits setback 4:51 AM 8/18/2009
Reuters
Arzerra's failure to help patients with non-Hodgkin's lymphoma (NHL) will also hit Genmab's bottom line in 2009 due to missed milestone payments from partner GlaxoSmithKline. ...

Lilly Says Patent for Gemzar Cancer Drug Invalidated 3:51 AM 8/18/2009
Bloomberg
Eli Lilly & Co’s 2013 method of use patent for cancer drug Gemzar (gemcitabine) was invalidated by a federal court. The compound patent remains in force through 2010. ...

Blood pressure drug reverses MS symptoms in mice 2:24 PM 8/17/2009
Reuters
The widely used blood pressure drug lisinopril may hold promise as a treatment for multiple sclerosis. ...

<- Day Earlier | Today's News